Search

everythinglearnresearchcommunity

for

Search:↓

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

A unique case showed a rare combination of two types of lichen planus on the face.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Graham-Little Piccardi Lassueur Syndrome is a rare skin condition with specific hair loss and skin symptoms.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.